Aclidinium bromide
CAS No. 320345-99-1
Aclidinium bromide ( LAS 34273; LAS-W 330 )
Catalog No. M14042 CAS No. 320345-99-1
Aclidinium Bromide inhibits human muscarinic AChR M1, M2, M3, M4 and M5 with Ki of 0.1 nM, 0.14 nM, 0.14 nM, 0.21 nM and 0.16 nM, respectively.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 30 | In Stock |
|
5MG | 47 | In Stock |
|
10MG | 73 | In Stock |
|
25MG | 133 | In Stock |
|
50MG | 241 | In Stock |
|
100MG | 404 | In Stock |
|
500MG | 887 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAclidinium bromide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAclidinium Bromide inhibits human muscarinic AChR M1, M2, M3, M4 and M5 with Ki of 0.1 nM, 0.14 nM, 0.14 nM, 0.21 nM and 0.16 nM, respectively.
-
DescriptionAclidinium Bromide inhibits human muscarinic AChR M1, M2, M3, M4 and M5 with Ki of 0.1 nM, 0.14 nM, 0.14 nM, 0.21 nM and 0.16 nM, respectively.
-
SynonymsLAS 34273; LAS-W 330
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorM1 mAChR; M2 mAChR; M3 mAChR; M4 mAChR; M5 mAChR
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number320345-99-1
-
Formula Weight564.55
-
Molecular FormulaC26H30NO4S2·Br
-
Purity>98%(HPLC)
-
SolubilityDMSO: 113 mg/mL (200.15 mM)
-
SMILESO=C(O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)C(C4=CC=CS4)(O)C5=CC=CS5.[Br-]
-
Chemical Name[(8R)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octan-8-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate bromide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sentellas S, et al. Eur J Pharm Sci, 2010, 39(5), 283-290.
molnova catalog
related products
-
Swertisin
Swertisin, a novel herbal biomolecule, shows a strong antihyperglycemic action.
-
mAChr-in-1
mAChR-IN-1 is muscarinic cholinergic receptor(mAChR) antagonist (IC50=17 nM).
-
Mecamylamine hydroch...
A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier.